"The potential to one day treat patients noninvasively with a single dose of radiation that ablates the tumor and avoids surgery could revolutionize our field," Trovò said. "It would reduce the burden of treatment on patients while lowering the costs for our society."
GammaPod has received 510(k) clearance from the FDA. In Europe, GammaPod is for investigational use only and cannot be marketed or put into service until it has been made to comply with the Medical Device Directive (93/42/EEC). In Italy, Tema Sinergie S.p.A. is the exclusive distributor of the GammaPod system.
About Xcision Medical Systems
Xcision Medical Systems, LLC is a medical technology company developing advanced stereotactic radiotherapy solutions with the potential to dramatically raise the quality of treatments and improve the lives of patients and their loved ones. The company's solutions are designed to extend the benefits of radiation oncology to more patients and enable noninvasive treatments that allow patients to return to living fuller lives more quickly and less painfully after receiving a cancer diagnosis.
SOURCE Xcision Medical Systems, LLC
Back to HCB News
